Letter: switching from one to another anti‐tumour necrosis factor alpha agent, and the risks of an overlap of exposure. Issue 9 (May 2016) - Macaluso, F. S.; Criscuoli, V.; Orlando, E.; Rizzuto, G.; Renna, S.; Cottone, M.; Orlando, A.